BIOVIA The CDMO Opportunity
The CDMO Opportunity
“The CDMO space is expected to accelerate in growth by at least 50% to a $150B market by 2025.”
Contract Development and Manufacturing Organizations (CDMOs) are becoming increasingly critical as service providers to pharmaceutical organizations seeking to outsource the development and manufacturing of their products.
The demand from small and medium-sized drug companies increases but competition on a local and global level is fierce. To grab these new opportunities, CDMOs must demonstrate their technical, regulatory, and manufacturing experience and excellence.
Explore Manufacturing Analytics and Quality and Compliance solutions to:
- control product quality, variability, and yield
- empower production operations
- accelerate time-to-market
- maximize efficiency and profitability
Gain access to white papers, fact sheets, and case studies for key solutions to seize the CDMO opportunity.
